Sector: Pharmaceuticals & Biotechnology

Large Cap

Gland Pharma Share Price

GLAND

₹2,475

5.50(0.22%)

10th Jul 2026 | 3:28 PM

NSE : GLAND

Open Free Demat Account

Gland Pharma Performance

Price Movement

₹2475.00

₹2451.00

₹2526.90

↘ Today's Low↗ Today's High

1 Year Performance

₹2475.00

₹1573.60

₹2573.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,526.90

Low₹2,451.00

Open at₹2,473.90

Prev Close₹2,469.50

Volumes3.29 L

Avg Price₹2,491.65

Lower Circuit₹1,975.60

Upper Circuit₹2,963.40

Historical Performance

3M High₹2,573.50

3M Low₹1,693.30

1 Yr High₹2,573.50

1 Yr Low₹1,573.60

3 Yr High₹2,573.50

3 Yr Low₹1,056.65

5 Yr High₹4,350.00

5 Yr Low₹861.00

Summary

As of 10-07-2026 20:24, Gland Pharma Ltd. share price today is ₹0, with a change of ₹-2469.50 (-100.00%) from the previous close of ₹2469.5. The stock opened at ₹2473.9 and traded between ₹2451 and ₹2526.9, with a total traded volume of 329308 shares. The company has a market capitalization of ₹40736.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2573.5 and ₹1573.6, respectively.

Gland Pharma Ltd. valuation metrics include a P/E ratio of 39.7, EPS of ₹62.35, and book value of ₹3.90. Profitability indicators show ROE of 9.91% along with a dividend yield of 0.7%. Gland Pharma Ltd. has reported revenue of ₹6430.65 Cr and net profit of ₹1027.32 Cr.

Gland Pharma Ltd. technical indicators include Day RSI at 63.24, Day MFI at 68.71, Day ADX at 45.72. Additional indicators include Commodity Channel Index (CCI) at 85.7 and Williams %R at -26.42. Momentum indicators show Day MACD at 89.54, Day MACD Signal Line at 82.06, DayATR at 84.68. Rate of Change indicators for Gland Pharma Ltd. include ROC125 at 43.93 and ROC21 at 7.91.

Exponential moving averages include EMA5 at ₹2479.4, EMA10 at ₹2443.4, EMA12 at ₹2428.5, EMA20 at ₹2375.4, EMA26 at ₹2339, EMA50 at ₹2213.8, EMA100 at ₹2062.2, EMA200 at ₹1943. Simple moving averages include SMA5 at ₹2488.2, SMA10 at ₹2453.5, SMA20 at ₹2345.3, SMA30 at ₹2318.9, SMA50 at ₹2186.6, SMA100 at ₹1964.1, SMA150 at ₹1885.4, SMA200 at ₹1891.9.

Support levels for Gland Pharma are placed at First Support ₹2447.13, Second Support ₹2424.77, Third Support ₹2387.33. Resistance levels are seen at First Resistance ₹2506.93, Second Resistance ₹2544.37, Third Resistance ₹2566.73. Gland Pharma Ltd. shareholding pattern shows promoter holding at 51.83%, FII holding at 7.29%, DII holding at 0%, public holding at 7.52%.

Gland Pharma Fundamentals

Market Cap

High in industry

40,736.80 Cr.

PE Ratio (TTM)

Above industry Median

39.70

Dividend Yield

Above industry Median

0.70

Net Profit TTM

47.1% incr over last year

1,027.32

Net Profit Growth

47.1% incr over last year

1,027.32

PEG Ratio

Above industry Median

0.80

ROE

29.9% incr over last year

9.91

Operating Revenue TTM

6,430.65

Operating Revenue Growth

14.5% incr over last year

Book Value

Above industry Median

3.90

MFI

MFI is mid-range

68.71

RSI

RSI is mid-range

63.24

EPS (TTM)

62.35

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

24.15

Operating Profit Qtr.

513.02

Net Profit Qtr.

366.68

Operating Revenue Qtr.

1,742.79

PB Ratio

3.90

Gland Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	1,261.59	1,177.51	1,074.15	1,038.84	1,030.35
Operating Expense	753.88	755.89	699.26	679.99	636.23
Operating Profit	507.72	421.63	374.89	358.84	394.12
Depreciation	43.11	44.53	44.84	43.77	43.07
Interest	6.16	0.50	3.97	7.44	3.45
Tax	144.35	104.61	106.68	93.12	101.32
Net Profit	420.45	307.85	302	269.26	290

Gland Pharma Technicals

Gland Pharma Ltd. EMA & SMA

₹2475.00

-20.80 (-0.83%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2479.4

Day EMA10 ₹2443.4

Day EMA12 ₹2428.5

Day EMA20 ₹2375.4

Day EMA26 ₹2339

Day EMA50 ₹2213.8

Day EMA100 ₹2062.2

Day EMA200 ₹1943

Gland Pharma Support and Resistance

Resistance

First Resistance₹2506.93

Second Resistance₹2544.37

Third Resistance₹2566.73

Support

First Support₹2447.13

Second Support₹2424.77

Third Support₹2387.33

Technical Indicators

Day RSI63.24

Day MFI68.71

Day ADX45.72

Day Commodity Channel Index85.70

William-26.42

Day MACD89.54

Day MACD Signal Line82.06

Day ATR84.68

Day ROC12543.93

Day ROC217.91

Gland Pharma Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	5	6.9	7.4	7.9	7.6	7.3
DII	34.8	33.3	32.8	32.6	33	33.3
Public	8.3	8	7.9	7.6	7.6	7.5

Gland Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2 L	3.74 L	53.49%
Week	3.74 L	7.74 L	48.26%
1 Month	4.64 L	9.38 L	49.46%
6 Month	1.9 L	4.29 L	44.24%

Gland Pharma SWOT Analysis

Strengths23

Weakness5

Opportunity3

Threats1

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Stocks with High Durability and EPS growth (subscription)

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Companies with high TTM EPS Growth

Strong QoQ EPS Growth in recent results

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Increasing profits every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Gland Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
14 Aug, 2025	18	FINAL	14 Aug, 2025	Equity Share
16 Aug, 2024	20	FINAL	16 Aug, 2024	Equity Share

Gland Pharma Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹754.95	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	0.39%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,124.33	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹591.79	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	71.60	75.10	37.10	54.70	-70.30
1 Year Return	190.14	31.93	57.98	43.82	0.21	-14.62
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

DIVISLAB

Divi's Laboratories Ltd.

₹ 6830.50

+0.26%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on GLAND

What is the current share price of Gland Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Gland Pharma Ltd. is ₹ 2475 on the NSE and ₹ 2478 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Gland Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Gland Pharma Ltd. is approximately ₹ 40736.8 Cr.

What are the PE and PB ratios for Gland Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Gland Pharma Ltd. is 39.7, and the Price-to-Book (PB) ratio is 3.9.

What is the 52-Week High and Low for Gland Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Gland Pharma Ltd. shares was ₹ 2573.5, and the lowest price was ₹ 1573.6.

What is the current dividend yield for Gland Pharma Ltd.?

As of 6 June 2025, the dividend yield for Gland Pharma Ltd. is 0.7%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Gland Pharma Ltd.?

Significant shareholdings in Gland Pharma Ltd. typically include entities such as:

Promoter
Mutual Funds
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Gland Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Gland Pharma Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Gland Pharma Ltd.?

Gland Pharma Ltd. last declared a FINAL dividend of ₹ 18 per share for the financial period ending 2025. The record date was set as 2025-08-14, and the payment was/is scheduled around 2025-08-14. For the most current dividend announcements, refer to official company filings.